跳至主要内容
临床试验/ITMCTR2100005174
ITMCTR2100005174尚未招募未知

A clinical trial study of a traditional Chinese medicine prescription combined with balance acupuncture in the treatment of migraine

Affiliated Hospital of Changchun University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 65(—)
性别
All

入选标准

  • 1.Meet the diagnostic criteria of Western medicine for migraine (migraine with aura or migraine without aura);
  • 2.Patients who meet the diagnostic criteria of liver-yang hyperactivity syndrome based on TCM differentiation;
  • 3.4 points <= VAS score <= 8 points, which affects work and study;
  • 4.For 3 months, the number of headache attacks every 4 weeks without aura migraine is more than 5 times (including 5 times); migraine with aura is more than 2 times (including 2 times);
  • 5.The age is between 18 and 65 years old; the age of first onset is =50 years old;
  • 6.The patient gave informed consent and signed the informed consent form.

排除标准

  • 1.Headache, but as a symptom of other diseases, such as hypertensive headache, cerebral hemorrhage brain disease, post-traumatic headache, intracranial low pressure headache, headache caused by intracranial space-occupying lesions, and ENT eye , Ear, nose, and paranasal sinus disease accompanied by headache, poisoning, febrile and other headaches;
  • 2.Special types of migraine, such as ophthalmoplegia, hemiplegic migraine, basilar artery migraine, etc.;
  • 3.Other types of headaches such as tension-type headaches, cluster headaches and neurotic headaches;
  • 4.Those who take painkillers or who are dependent on painkillers during the trial period;
  • 5.Take medicines that may have the effect of preventing and curing headache attacks (such as sibilene, nimodipine, etc.) for 3 months;
  • 6.Patients with severe cardiopulmonary insufficiency, severe primary diseases such as liver, kidney, hematopoietic system, mental illness, gastrointestinal diseases that seriously affect drug absorption;
  • 7.Patients who have used antipsychotics or antidepressants 3 months before the test;
  • 8.Suspected or true history of alcohol or drug abuse, or other diseases or conditions that reduce the possibility of enrollment or complicate enrollment according to the judgment of the investigator, such as frequent changes in the working environment and cause loss to follow-up.

研究者

发起方
Affiliated Hospital of Changchun University of Traditional Chinese Medicine

相似试验